Development and Clinical Application of Invalid Foods Using Mealworms
NCT ID: NCT03201926
Last Updated: 2019-01-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
168 participants
INTERVENTIONAL
2017-06-26
2020-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Validation of Nutritional Supplements("Ketogenic Plus") Developed for Pancreaticobiliary Cancer Patients
NCT03510429
Clinical Validation of Nutritional Supplements Developed for Pancreaticobiliary Cancer Patients
NCT03294096
Clinical Application of Nutrition Support Package Before Hepatectomy
NCT04218253
Development and Clinical Validation of Ketogen-based Therapeutic Diet for Pancreaticobiliary Cancer Patients
NCT02964806
Oral Supplementation of Glutamine on Gastric Cancer Patients After Gastrectomy
NCT06027242
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
mealworms
mealworms
mealworms
10g , 3 times a day , po, 2 months
grain powder
grain powder
grain powder
grain powder, 10g ,3times one day,2months
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
mealworms
10g , 3 times a day , po, 2 months
grain powder
grain powder, 10g ,3times one day,2months
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Karnofsky performance status ≥ 70
* Patients who can communicate without difficulty in obtaining a consent form for the test
Exclusion Criteria
* Patients with uncontrolled pre-operative disease
* Previous history of surgery affecting nutritional status
* Pregnant and lactating women
* Patients with allergy to mealworms
19 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Yonsei University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Joon Seong Park
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Gangnam Severance Hospital
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
JoonSeong Park
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Kim HS, Lee YS, Jang SY, Jun SY, Lim JH, Kim IK, Kim HM, Park JS. Clinical application of invalid foods using mealworms and evaluation of nutrition status and immune function: a study protocol for a randomized, double blind, placebo-controlled trial. BMC Nutr. 2019 Nov 18;5:44. doi: 10.1186/s40795-019-0307-6. eCollection 2019.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
3-2017-0077
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.